|
Market Closed -
Nasdaq
01:30:00 13/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 31.42 USD | +1.85% |
|
+7.38% | +2.01% |
| 12/08 | BNP Paribas Initiates Genmab at Outperform, With $40 Price Target | MT |
| 12/08 | Nordic stocks in North America: AstraZeneca fell 1.0% | FW |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | ||
| 180.81 | +13.69% | 18 | ||||||
| 1,037.68 | +18.14% | 15 | ||||||
| 200.05 | +51.23% | 22 | ||||||
| 40.89 | +4.06% | 23 | ||||||
| 104.26 | +29.97% | 20 | ||||||
| 1,073.31 | -25.46% | 7 | ||||||
| 2,410.59 | +18.34% | 15 | ||||||
| 570.05 | +7.86% | 18 | ||||||
| 52.94 | +5.08% | 16 | ||||||
| 110.18 | +26.28% | 11 | ||||||
| 678.06 | +26.46% | 16 | ||||||
| 21.11 | +88.78% | 13 | ||||||
| 144.21 | +64.36% | 21 | ||||||
| 109.15 | +44.3% | 20 | ||||||
| 99.56 | +40.78% | 16 | ||||||
| 124.71 | +19.81% | 14 | ||||||
| 85.5 | +1.23% | 10 | ||||||
| 109 | +82.73% | 9 | ||||||
| 12.75 | +64.73% | 4 | ||||||
| Average | 377.1 | +30.65% | 15 | ||||||
| Weighted average by Cap. | 460.31 | +24.52% | 16 |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Sector Genmab A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
